Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Melisi

Showing results (71-80 of 119) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|April 1, 2026
Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trialAnne M Gehrels, Esther N Pijnappel, Eva H van Daalen, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 29, 2020
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunitiesClaudio Luchini, Gaetano Paolino, Paola Mattiolo, et al.
Journal of Personalized Medicine|September 28, 2023
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric CancerMaria Bencivenga, Lorena Torroni, Mariagiulia Dal Cero, et al.
Free Radical Biology & Medicine|August 13, 2017
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertensionEnrica Federti, Alessandro Matté, Alessandra Ghigo, et al.
Therapeutic Advances in Medical Oncology|March 5, 2020
Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trialRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.
Blood|January 29, 2020
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusionShin-Young Park, Alessandro Matte, Yookyung Jung, et al.
Data in Brief|October 17, 2017
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasisEnrica Federti, Alessandro Matte, Alessandra Ghigo, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2018
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorinRichard A Hubner, Antonio Cubillo, Jean-Frédéric Blanc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Expert Review of Gastroenterology & Hepatology|December 10, 2021
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter studyMassimiliano Salati, Alessandro Rizzo, Valeria Merz, et al.
Pageof 12

Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|April 1, 2026
Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trialAnne M Gehrels, Esther N Pijnappel, Eva H van Daalen, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 29, 2020
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunitiesClaudio Luchini, Gaetano Paolino, Paola Mattiolo, et al.
Journal of Personalized Medicine|September 28, 2023
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric CancerMaria Bencivenga, Lorena Torroni, Mariagiulia Dal Cero, et al.
Free Radical Biology & Medicine|August 13, 2017
Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertensionEnrica Federti, Alessandro Matté, Alessandra Ghigo, et al.
Therapeutic Advances in Medical Oncology|March 5, 2020
Early intravenous administration of nutritional support (IVANS) in metastatic gastric cancer patients at nutritional risk, undergoing first-line chemotherapy: study protocol of a pragmatic, randomized, multicenter, clinical trialRiccardo Caccialanza, Emanuele Cereda, Catherine Klersy, et al.
Blood|January 29, 2020
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversed by blood transfusionShin-Young Park, Alessandro Matte, Yookyung Jung, et al.
Data in Brief|October 17, 2017
Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasisEnrica Federti, Alessandro Matte, Alessandra Ghigo, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2018
Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorinRichard A Hubner, Antonio Cubillo, Jean-Frédéric Blanc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Expert Review of Gastroenterology & Hepatology|December 10, 2021
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter studyMassimiliano Salati, Alessandro Rizzo, Valeria Merz, et al.
Pageof 12